Sharon Mates - Dec 13, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chairman, President & CEO, Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Dec 13, 2022
Transactions value $
-$1,819,565
Form type
4
Date filed
12/15/2022, 06:01 PM
Previous filing
Mar 14, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale -$1.82M -33.1K -2.92% $55.00 1.1M Dec 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.